Florida Department of Health Funding Organization
Research
awards grant
- A Comparison of Latino and White Construction Workers¿ Safety and Health in South Florida
- A Consortium to Study Novel Markers of Early Alzheimer's disease
- A micro-fabricated in vivo bubble oxygenator for the treatment of induced severe pulmonary disease.
- Biobehavioral Intervention For Smokers Living With HIV
- Conformational Dynamics in Vertebrate Hexacoordiante Hemoglobins
- Cytokines an underlying cause of health disparities in tobacco related diseases
- Demographic, Neuropsychological and Functional Classification, Risk Factors, and Progression Rates of Individuals Diagnosed as "Impaired Not MCI" in the National Alzheimer's
- Development of high-throughput assays to identify drugs to prevent arsenic carcinogenesis
- Development of nanoscale approaches for Zika virus pathogenesis and therapeutics
- Diagnostic Mammography Using Real Time Co-Registering Novel Hand-Held Optical Imager.
- Enhancing the Activity of Anticancer Drugs by a Natural Product - Phycocyanin
- Healthy Food Access and Policy Change
- Hispanic/Latino Tobacco Network
- Identifying Molecular Targets for Spatial Mosquito Repellent Design
- Image Guided Intervention for Breast Cancer: Combined Hyperthermia and Chemotherapy with Reduced Cardiotoxicity.
- Institute on Aging and Health Appropriation
- Menthol or Not menthol: How Smoking is related to Bone Mineral Density in People With and Without HIV
- Metastases and Promotion of Aggressive Neovascular Phenotype in Breast Cancer.
- Miami-Dade Drowning Prevention Campaign 2006-2007.
- PROMOTE AND COORDINATE HIGH-IMPACT HIV/AIDS RESEARCH IN SOUTH FLORIDA
- Personalized Ex Vivo Drug Screening and Genomics Profiling to Guide Individualized Treatments for Children with Relapsed or Refractory Solid Tumors and Leukemias
- Restoring the Mucociliary clearance enhancing properties of inhaled beta-2-agonist bronchodilators in chronic bronchitis.
- The Airway Microbiome in Chronic Obstructive Pulmonary Disease
- Therapeutic role of Withaferin A and CRID3 in the prevention of AD. A Novel Nanotechnology Approach
- Vascular effects of relaxin receptor agonists